Sanofi Pasteur Teams Up With Institut Pasteur To Develop Malaria Vaccine

by Medindia Content Team on  October 16, 2007 at 12:26 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Sanofi Pasteur Teams Up With Institut Pasteur To Develop Malaria Vaccine
Sanofi Pasteur, the vaccine unit of pharmaceutical company Sanofi Aventis, plans to partner with the Institut Pasteur, a French health sciences laboratory, to develop a malaria vaccine candidate, the drug maker announced on Monday, Thomson Financial/Forbes reports.

Under the partnership agreement, Sanofi Pasteur researchers will have access to Plasmodium falciparum antigens that have been identified by scientists at Institut Pasteur. According to Institut Pasteur President Alice Dautry, the lab has discovered "several promising antigens over the last decade" that could lead to the development of a malaria vaccine "to protect children living in endemic regions" and other groups. Sanofi Pasteur's malaria vaccine project is in the preclinical phase, the company said.

Dautry said the partnership "increases the potential" of reaching the "shared goal of a malaria vaccine" and will reinforce the groups' collaboration to "benefit public health".

Source: Kaiser Family Foundation
VEN/C

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Malaria-water Malaria Mosquito Diseases Fever 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive